Company Profile

Public information reviewed
Eledon Pharmaceuticals, Inc. logo

Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating innovative treatments for individuals battling autoimmune disorders, amyotrophic lateral sclerosis (ALS), and those undergoing organ or cell…

USNASDAQ: ELDN
Follow
More
Reports & analysisAlpha EvalSave PDF
Public sources
1 reviewed
Published leadership records
8
Last reviewed
Sep 16, 2026
View sources

Agent View

Machine representations

Inspect the same governed public record as Markdown, structured data, or a retrieval endpoint.

Canonical entity
alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63
Schema
alpha.governance.entity.public.v1
Last reviewed
2026-09-16T04:46:30.336153+00:00
Verification
source_reported
Ownership
unclaimed

Markdown

https://registry.alpha.ac/companies/eledon-pharmaceuticals-inc.md
Open Markdown

Eledon Pharmaceuticals, Inc.

Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

Record

FieldValue
Representationalpha-profile-markdown-v3
ProtocolAlpha Governance Facts Protocol 0.1
Schemaalpha.governance.entity.public.v1
Record versionpublic-1
Canonical entityalpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63
Entity typeCompany
Canonical URLhttps://registry.alpha.ac/companies/eledon-pharmaceuticals-inc
PublicationPUBLISHED
Verificationsource_reported
Verification schemaalpha-verification-states-v1
Ownershipunclaimed
Published claims13
Claims under review1
Evidence records2
Conflicts0
Conflicts in internal review0
Observed2026-09-16T04:46:30.336153+00:00
Last reviewed2026-09-16T04:46:30.336153+00:00

Identity

  • Legal name: Eledon Pharmaceuticals, Inc.
  • Display name: Eledon Pharmaceuticals, Inc.

Leadership

  • Allan D. Kirk, M.D., Ph.D., FACS: Director. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:2.
  • David-Alexandre C. Gros, M.D.: Director. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:2.
  • James Robinson: Director. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:2.
  • Jan Hillson, M.D.: Director. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:2.
  • John S. McBride: Director. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:2.
  • June Lee, M.D.: Director. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:2.
  • Keith A. Katkin: Director. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:2.
  • Steven Perrin, Ph.D.: Director. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:2.

Roles

  • PUBLISHED

Governance

  • NOT_ASSERTED

Board committees

  • PUBLISHED

Financials

  • NOT_ASSERTED

Workforce

  • NOT_ASSERTED

Market and index context

  • PUBLISHED

Legal Name

  • Eledon Pharmaceuticals, Inc.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:1.

Headquarters

  • US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.

Entity Status

  • Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:1.

Published Fact

  • US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:1.
  • Healthcare. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:1.
  • Biotechnology. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:1.

Coverage states

FieldValue
IdentityPUBLISHED
BusinessPUBLISHED
LeadershipPUBLISHED
Board and committeesPUBLISHED
GovernanceNOT_ASSERTED
FinancialsNOT_ASSERTED
WorkforceNOT_ASSERTED
OwnershipNOT_ASSERTED
RatingsNOT_PUBLISHED
Market and index contextPUBLISHED

Public sources

Rights

FieldValue
public_retrievalallowed
agent_retrievalallowed
redistributionnot_granted
model_trainingnot_granted
commercial_usenot_specified
relationship_pathfindingnot_granted
direct_contactnot_granted

Limitations

  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.

Alternate representations